The Biotech sector just keeps on going. Exhibit A is AMGN, which this space noted had a target of 174 back in March when the price popped above 160. Here’s the updated chart from that post. It’s had a subsequent drop and rebound, keeping 174 in view.

We had an NFTRH+ update on an interesting pattern in GILD (daily and weekly charts were analyzed for subscribers) along with an upside target and stop loss parameters. GILD has been forming this pattern for months now.

Today was interesting because several smaller, more speculative Bio’s were weak while the big boys were strong.  Here is the updated chart of the Biotech ETF (IBB), near the top of its channel.

What’s it mean?  Simply that an important market leader is still fully intact.  On that note, here is the BTK secular bull vs. NDX chart once again.  This secular bull is 15 years old.  Read into it what you may.